Ameriprise’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.15M | Buy |
170,728
+148,752
| +677% | +$5.36M | ﹤0.01% | 2202 |
|
|
2025
Q1 | $684K | Sell |
21,976
-2,256
| -9% | -$70.2K | ﹤0.01% | 3344 |
|
|
2024
Q4 | $618K | Sell |
24,232
-23,786
| -50% | -$607K | ﹤0.01% | 3417 |
|
|
2024
Q3 | $1.36M | Buy |
48,018
+3,024
| +7% | +$85.6K | ﹤0.01% | 3080 |
|
|
2024
Q2 | $1.19M | Sell |
44,994
-132,364
| -75% | -$3.49M | ﹤0.01% | 3088 |
|
|
2024
Q1 | $5.39M | Buy |
177,358
+10,806
| +6% | +$328K | ﹤0.01% | 2313 |
|
|
2023
Q4 | $4.68M | Sell |
166,552
-2,271,500
| -93% | -$63.8M | ﹤0.01% | 2394 |
|
|
2023
Q3 | $66.2M | Buy |
2,438,052
+229,165
| +10% | +$6.22M | 0.02% | 640 |
|
|
2023
Q2 | $67.9M | Buy |
2,208,887
+723,451
| +49% | +$22.2M | 0.02% | 635 |
|
|
2023
Q1 | $53.5M | Buy |
1,485,436
+98,288
| +7% | +$3.54M | 0.02% | 723 |
|
|
2022
Q4 | $54.8M | Buy |
1,387,148
+12,907
| +0.9% | +$510K | 0.02% | 688 |
|
|
2022
Q3 | $55.2M | Buy |
1,374,241
+84,542
| +7% | +$3.4M | 0.02% | 662 |
|
|
2022
Q2 | $54.2M | Sell |
1,289,699
-2,418
| -0.2% | -$102K | 0.02% | 685 |
|
|
2022
Q1 | $50.3M | Sell |
1,292,117
-8,554
| -0.7% | -$333K | 0.01% | 810 |
|
|
2021
Q4 | $51.8M | Buy |
1,300,671
+8,410
| +0.7% | +$335K | 0.01% | 824 |
|
|
2021
Q3 | $46.7M | Sell |
1,292,261
-59,915
| -4% | -$2.17M | 0.01% | 799 |
|
|
2021
Q2 | $55.4M | Buy |
1,352,176
+88,292
| +7% | +$3.62M | 0.02% | 748 |
|
|
2021
Q1 | $55.2M | Buy |
1,263,884
+471,201
| +59% | +$20.6M | 0.02% | 730 |
|
|
2020
Q4 | $39.7M | Buy |
792,683
+171,965
| +28% | +$8.61M | 0.01% | 855 |
|
|
2020
Q3 | $26.1M | Sell |
620,718
-804,652
| -56% | -$33.9M | 0.01% | 937 |
|
|
2020
Q2 | $69.2M | Buy |
+1,425,370
| New | +$69.2M | 0.03% | 501 |
|